ARID1A deficiency impairs the DNA damage checkpoint [46], which is targeted by the MSI mechanism of DNA damage in gastric cancer [43], and ARID1A recruits MSH2 to chromatin during DNA replication and promotes MMR [47]. This evidence concerns the gene MSH2 and gastric cancer.